Vineeta Agarwala

Bio

Vineeta Agarwala is a General Partner at Andreessen Horowitz where she leads investments for the firm’s bio fund across therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery. Prior to joining a16z, Vineeta has held many different roles in the healthcare space: as a physician taking care of patients; as an operator at tech-driven healthcare companies; and most recently as a venture investor on the GV (Google Ventures) life sciences team. At GV, she focused on biotech companies with a data-driven approach, and invested in and worked with a wide range of companies including Maze Therapeutics, Locana, Spero Therapeutics, and Ideaya Biosciences. Previously, she was an early data scientist at Kyruus; a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Co; and a Director of Product Management at Flatiron Health, where she led the company’s partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale database products to accelerate drug development and research in oncology. She has collaborated with academic researchers at Cold Spring Harbor Laboratory, Lawrence Livermore National Laboratory, and the Broad Institute, where she did graduate work in computational biology and human genetics. Vineeta holds a B.S. in biophysics from Stanford University, and M.D. and Ph.D. degrees from Harvard Medical School and MIT.